{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:27:47Z","timestamp":1793831267757,"version":"4.6.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.healun.2008.10.004","type":"journal-article","created":{"date-parts":[[2008,12,5]],"date-time":"2008-12-05T12:50:54Z","timestamp":1228481454000},"page":"58-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Tacrolimus Versus Cyclosporine Microemulsion for Heart Transplant Recipients: A Meta-analysis"],"prefix":"10.1016","volume":"28","author":[{"given":"Fan","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ying-Bin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weng","family":"Yu-Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Hetzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2008.10.004_bib1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.healun.2007.06.004","article-title":"Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplantation report\u20142007","volume":"26","author":"Taylor","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2008.10.004_bib2","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1136\/bmj.318.7191.1104","article-title":"Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials","volume":"318","author":"Knoll","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.healun.2008.10.004_bib3","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/j.1600-6143.2006.01360.x","article-title":"Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis","volume":"6","author":"McAlister","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2008.10.004_bib4","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bmj.38569.471007.AE","article-title":"Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data","volume":"331","author":"Webster","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.healun.2008.10.004_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.healun.2008.10.004_bib6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.healun.2008.10.004_bib7","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1097\/00007890-200212150-00014","article-title":"Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression","volume":"74","author":"Mehra","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2008.10.004_bib8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/01.TP.0000129814.52456.25","article-title":"Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients?","volume":"78","author":"Meiser","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2008.10.004_bib9","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.transproceed.2004.08.059","article-title":"Efficacy and safety of tacrolimus versus cyclosporine microemulsion in primary cardiac transplant recipients: 6-month results in Taiwan","volume":"36","author":"Wang","year":"2004","journal-title":"Transplant proc"},{"key":"10.1016\/j.healun.2008.10.004_bib10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.healun.2004.11.006","article-title":"Randomized clinical trial of tacrolimus- vs cyclosporine-based immunosuppression in pediatric heart transplantation: preliminary results at 15-month follow-up","volume":"24","author":"Pollock-Barziv","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2008.10.004_bib11","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1600-6143.2006.01300.x","article-title":"Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients--a large European trial","volume":"6","author":"Grimm","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2008.10.004_bib12","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1600-6143.2006.01290.x","article-title":"Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report","volume":"6","author":"Kobashigawa","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2008.10.004_bib13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.healun.2005.11.452","article-title":"Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients","volume":"25","author":"Kobashigawa","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2008.10.004_bib14","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0041-1345(01)01906-6","article-title":"Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up?","volume":"33","author":"Groetzner","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2008.10.004_bib15","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1053-2498(98)00060-6","article-title":"A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus","volume":"18","author":"Taylor","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2008.10.004_bib16","first-page":"775","article-title":"European Multicenter Tacrolimus (FK506) Heart Pilot Study: one-year results--European Tacrolimus Multicenter Heart Study Group","volume":"17","author":"Reichart","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2008.10.004_bib17","first-page":"782","article-title":"Single-center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection","volume":"17","author":"Meiser","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2008.10.004_bib18","first-page":"982","article-title":"Acute rejection and heart infection rates in FK 506- versus cyclosporine A-treated heart transplant recipients: an endomyocardial biopsy pathologic study","volume":"16","author":"Arbustini","year":"1997","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2008.10.004_bib19","first-page":"1001","article-title":"FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study","volume":"16","author":"Rinaldi","year":"1997","journal-title":"J Heart Lung Transplant"},{"issue":"suppl","key":"10.1016\/j.healun.2008.10.004_bib20","first-page":"133","article-title":"Comparison between tacrolimus (FK506) and cyclosporin A (CyA) after heart transplantation: a randomised, controlled clinical study","volume":"85","author":"Meiser","year":"1996","journal-title":"Z Kardiol"},{"key":"10.1016\/j.healun.2008.10.004_bib21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0002-9149(99)00631-1","article-title":"Cyclosporine versus tacrolimus (FK 506) for prevention of cardiac allograft vasculopathy","volume":"85","author":"Klauss","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2008.10.004_bib22","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jacc.2005.10.073","article-title":"Coronary endothelial vasomotor function and vascular remodeling in heart transplant recipients randomized for tacrolimus or cyclosporine immunosuppression","volume":"47","author":"Petrakopoulou","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2008.10.004_bib23","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/01.tp.0000232286.22319.e0","article-title":"Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus","volume":"82","author":"White","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2008.10.004_bib24","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.transproceed.2004.08.053","article-title":"Therapeutic drug monitoring of tacrolimus in cardiac transplant recipients: a comparison with cyclosporine Neoral","volume":"36","author":"Wang","year":"2004","journal-title":"Transplant Proc"},{"issue":"suppl 1","key":"10.1016\/j.healun.2008.10.004_bib25","doi-asserted-by":"crossref","first-page":"S609","DOI":"10.1111\/j.1432-2277.2000.tb02117.x","article-title":"Assessment of health-related quality-of-life in patients after heart transplantation under therapy with tacrolimus or cyclosporine","volume":"13","author":"von Steinb\u00fcchel","year":"2000","journal-title":"Transplant international"},{"key":"10.1016\/j.healun.2008.10.004_bib26","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0041-1345(00)02611-7","article-title":"A randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients","volume":"33","author":"Mehra","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2008.10.004_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/00007890-200407271-00420","article-title":"A randomized, prospective, multicenter comparison of tacrolimus, mycophenolate mofetil (MMF) and steroids vs cyclosporine microemulsion, MMF and steroids vs tacrolimus, sirolimus and steroids in de novo cardiac transplant recipients - 6 month report","author":"Kobashigawa","year":"2004"},{"key":"10.1016\/j.healun.2008.10.004_bib28","first-page":"47","article-title":"First year results of a randomized trial of tacrolimus vs Neoral cyclosporine in heart transplant patients","volume":"19","author":"Kobashigawa","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2008.10.004_bib29","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2008.10.004_bib30","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1097\/00007890-200206150-00019","article-title":"Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production","volume":"73","author":"Jiang","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2008.10.004_bib31","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/00007890-199902270-00021","article-title":"Tacrolimus induces increased expression of transforming growth factor in mammalian lymphoid as well as non-lymphoid cells","volume":"67","author":"Khanna","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2008.10.004_bib32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00007890-199802150-00003","article-title":"In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine","volume":"65","author":"Shin","year":"1998","journal-title":"Transplantation"},{"issue":"suppl 9","key":"10.1016\/j.healun.2008.10.004_bib33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-6135.2004.00397.x","article-title":"Immunosuppression: practice and trends","volume":"4","author":"Kaufman","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2008.10.004_bib34","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.healun.2008.06.017","article-title":"Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report\u20142008","volume":"27","author":"Taylor","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2008.10.004_bib35","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.healun.2004.05.023","volume":"24","author":"White","year":"2005","journal-title":"J Heart Lung Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249808007377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249808007377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:17:27Z","timestamp":1760948247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249808007377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S1053249808007377"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2008.10.004","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tacrolimus Versus Cyclosporine Microemulsion for Heart Transplant Recipients: A Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2008.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2009 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}